• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP- NEWS BRIEFS April 23, 2026

Lance

MPH, CSP & CIT Retired, CHMM Emeritus
www.cidrap.umn.edu/all-news

Moderna’s combo flu-COVID vaccine receives European authorization


News brief

Today at 4:30 p.m.
Stephanie Soucheray, MA
Topics

COVID-19

Influenza Vaccines

The world’s first combination seasonal influenza and COVID-19 vaccine, Moderna’s mCombriax, has received marketing authorization from the European Commission, following a positive review from the European Medicines Agency’s Committee for Medicinal Products for Human Use.

“By combining protection against two significant respiratory viruses in a single dose, our vaccine aims to simplify immunization for adults, particularly those at high risk,” said Moderna CEO Stephane Bancel, MBA, in a press release. “mCOMBRIAX offers an important new option for Europeans, while also aiming to strengthen the resilience of healthcare systems across Europe."

Shot performed well in older adults


According to the company, mCombriax was based on the clinical development of mNexspike, Moderna's COVID-19 vaccine, and mRNA-1010, Moderna’s investigational seasonal influenza vaccine, which has been accepted for review in the European Union (EU), United States, Canada, and Australia.

The vaccine performed well in a phase 3 trial, where a single dose elicited statistically significant higher immune responses against three influenza virus strains (A/H1N1, A/H3N2, and B/Victoria) and against SARS-CoV-2 in adults 50 to 64 years and 65 years and older.

The marketing authorization is valid in all 27 EU member states, as well as Iceland, Liechtenstein, and Norway. No major safety concerns or adverse events were seen in the phase 3 trial.


More California marine mammals confirmed to have H5N1 avian flu, as USDA tracks poultry outbreaks in Midwest


News brief

Today at 3:47 p.m.
Stephanie Soucheray, MA
Topics

Avian Influenza (Bird Flu)
Eleven more marine mammals have been tested and confirmed to have H5N1 avian flu in an outbreak that spans four counties in California. The outbreak total now stands at 58 mammals, including 57sea lions and one otter. All but seven are from San Mateo County.

The outbreak started in February and marked the first H5N1 detection in marine mammals in California. Seals at the state park were observed with abnormal respirations, tremors, and neurologic symptoms.

Commercial detections dropping in April


In other avian flu news, four commercial poultry facilities, one each in North and South Dakota, Minnesota, and Georgia have reported new avian flu outbreaks. The outbreak in Minnesota’s Big Stone County involves 62,900 birds on a commercial turkey farm.

Commercial poultry detections have slowed this month compared with March, with 28 confirmed outbreaks in 20 commercial and eight backyard flocks. Roughly 700,000 birds have been affected in the past 30 days.

Wild bird detections have also dropped, with 13 notices from the US Department of Agriculture’s Animal and Plant Health Inspection Service (APHIS) in the past 10 days.

Of note, three Bald Eagles in Minnesota, Pennsylvania, and New York were confirmed to have the virus, as were four birds (gulls and a Red-necked phalarope) from San Mateo County, California, the same county with marine mammal detections.

ALL BRIEFS
 
Back
Top Bottom